IVVD - Invivyd, Inc.
0.8459
-0.069 -8.157%
Share volume: 3,688,359
Last Updated: 03-11-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$0.91
-0.07
-0.08%
View ratios
Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
---|---|---|---|---|
Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 05-09-2024 | 08-14-2024 | 11-14-2024 | |
Total revenue | 0.000 | 2.264 M | 9.300 M | |
Cost of revenue | 0.000 | 88.000 K | 806.000 K | |
Gross profit | 0.000 | 2.176 M | 8.494 M | |
inf% | 290.35% | |||
Operating expenses | 46.089 M | 51.423 M | 70.805 M | |
Selling general and admin | 14.929 M | 21.089 M | 12.955 M | |
Research and development | 31.160 M | 30.334 M | 57.850 M | |
Total expenses | 46.089 M | 51.423 M | 70.805 M | |
11.57% | 37.69% | |||
Operating income | -46.089 M | -49.247 M | -62.311 M | |
Ebit | -43.496 M | -47.247 M | -60.739 M | |
Pretax income | -43.496 M | -47.247 M | -60.739 M | |
8.62% | 28.56% | |||
Income tax | 0.000 | 0.000 | 0.000 | |
Net income basic | 0.000 | 0.000 | 0.000 | |
Net income | -43.496 M | -47.247 M | -60.739 M | |
-8.62% | -28.56% |